BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Flexion Therapeutics 

300 TradeCenter
Suite 2460
Woburn  Massachusetts  01801  U.S.A.
Phone: 781-897-9977 Fax: 781-897-9970


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Flexion Therapeutics (FLXN) Announces Exercise Of Underwriters' Over-Allotment Option And Closing Of Public Offering Of Common Stock 12/17/2014 7:47:55 AM
Flexion Therapeutics (FLXN) Announces Pricing Of Public Offering Of Common Stock 12/12/2014 7:25:05 AM
Flexion Therapeutics (FLXN) Announces Public Offering Of Common Stock 12/9/2014 11:08:16 AM
FDA Lifts Clinical Hold On Flexion Therapeutics (FLXN)'s FX006 For Osteoarthritis Pain 12/2/2014 6:25:57 AM
Flexion Therapeutics (FLXN) To Present At Stifel Healthcare Conference 2014 11/17/2014 2:40:35 PM
Flexion Therapeutics (FLXN) Reports Third-Quarter 2014 Financial Results 11/14/2014 8:15:22 AM
Flexion Therapeutics (FLXN) To Report Third-Quarter 2014 Financial Results 11/7/2014 7:57:52 AM
Flexion Therapeutics (FLXN) To Ring The Nasdaq Stock Market Opening Bel 10/22/2014 10:44:28 AM
Flexion Therapeutics (FLXN) Reports FDA Clinical Hold For Phase 2b Trial Of Osteoarthritis Drug 9/18/2014 6:57:27 AM
Flexion Therapeutics (FLXN) Announces Issuance Of U.S. Composition Of Matter Patent For Lead Candidate FX006 9/9/2014 9:39:39 AM
12345